152 related articles for article (PubMed ID: 33492804)
1. Immunophenotype of Vestibular Schwannomas.
Bi WL; Gupta S; Mei Y; Abdulmohsen SA; Giantini Larsen A; Unadkat P; Ramkissoon S; Abedalthagafi M; Dunn IF
Otol Neurotol; 2020 Dec; 41(10):e1290-e1296. PubMed ID: 33492804
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas.
de Vries M; Briaire-de Bruijn I; Malessy MJ; de Bruïne SF; van der Mey AG; Hogendoorn PC
Otol Neurotol; 2013 Feb; 34(2):347-52. PubMed ID: 23295727
[TBL] [Abstract][Full Text] [Related]
3. M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma.
de Vries WM; Briaire-de Bruijn IH; van Benthem PPG; van der Mey AGL; Hogendoorn PCW
Virchows Arch; 2019 Mar; 474(3):375-381. PubMed ID: 30580386
[TBL] [Abstract][Full Text] [Related]
4. Natural History of Sporadic Vestibular Schwannoma: A Volumetric Study of Tumor Growth.
Lees KA; Tombers NM; Link MJ; Driscoll CL; Neff BA; Van Gompel JJ; Lane JI; Lohse CM; Carlson ML
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):535-542. PubMed ID: 29685084
[TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
6. PD-L1 and PD-L2 Are Differentially Expressed by Macrophages or Tumor Cells in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
Menguy S; Prochazkova-Carlotti M; Beylot-Barry M; Saltel F; Vergier B; Merlio JP; Pham-Ledard A
Am J Surg Pathol; 2018 Mar; 42(3):326-334. PubMed ID: 29112015
[TBL] [Abstract][Full Text] [Related]
7. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas.
Dunn IF; Bi WL; Mukundan S; Delman BN; Parish J; Atkins T; Asher AL; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E32-E34. PubMed ID: 29309686
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of the tumor immune microenvironment in synovial sarcoma.
Oike N; Kawashima H; Ogose A; Hotta T; Hatano H; Ariizumi T; Sasaki T; Yamagishi T; Umezu H; Endo N
Cancer Sci; 2018 Oct; 109(10):3043-3054. PubMed ID: 30133055
[TBL] [Abstract][Full Text] [Related]
9. Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.
Harada K; Dong X; Estrella JS; Correa AM; Xu Y; Hofstetter WL; Sudo K; Onodera H; Suzuki K; Suzuki A; Johnson RL; Wang Z; Song S; Ajani JA
Gastric Cancer; 2018 Jan; 21(1):31-40. PubMed ID: 28801853
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous Volumetric Tumor Regression During Wait-and-Scan Management of 952 Sporadic Vestibular Schwannomas.
Marinelli JP; Killeen DE; Schnurman Z; Nassiri AM; Hunter JB; Lees KA; Lohse CM; Roland TJ; Golfinos JG; Kondziolka D; Link MJ; Carlson ML
Otol Neurotol; 2022 Oct; 43(9):e1034-e1038. PubMed ID: 36001695
[TBL] [Abstract][Full Text] [Related]
11. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort.
Gonçalves VM; Suhm EM; Ries V; Skardelly M; Tabatabai G; Tatagiba M; Schittenhelm J; Behling F
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530441
[TBL] [Abstract][Full Text] [Related]
12. Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas.
Tamura R; Morimoto Y; Sato M; Kuranari Y; Oishi Y; Kosugi K; Yoshida K; Toda M
J Neurooncol; 2020 Jan; 146(2):265-273. PubMed ID: 31897926
[TBL] [Abstract][Full Text] [Related]
13. Predominance of M1 subtype among tumor-associated macrophages in phenotypically aggressive sporadic vestibular schwannoma.
Perry A; Graffeo CS; Carlstrom LP; Raghunathan A; Driscoll CLW; Neff BA; Carlson ML; Parney IF; Link MJ; Van Gompel JJ
J Neurosurg; 2019 Oct; 133(6):1637-1645. PubMed ID: 31585433
[TBL] [Abstract][Full Text] [Related]
14. Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1) and strong immune-cell infiltration by TCD3 cells and macrophages.
Vieira T; Antoine M; Hamard C; Fallet V; Duruisseaux M; Rabbe N; Rodenas A; Cadranel J; Wislez M
Lung Cancer; 2016 Aug; 98():51-58. PubMed ID: 27393506
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.
Imai D; Yoshizumi T; Okano S; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Soejima Y; Aishima S; Oda Y; Maehara Y
Cancer Med; 2017 Jul; 6(7):1614-1626. PubMed ID: 28602029
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tumor microenvironment composition in vestibular schwannomas: insights into NF2-associated and sporadic variations and their clinical correlations.
Nickl V; Ziebolz D; Rumpel C; Klein D; Nickl R; Rampeltshammer E; Monoranu CM; Ernestus RI; Matthies C; Löhr M; Hagemann C; Breun M
Front Oncol; 2024; 14():1340184. PubMed ID: 38817895
[TBL] [Abstract][Full Text] [Related]
17. Vestibular Schwannoma Measurements-Is Volumetric Analysis Clinically Necessary?
Selleck AM; Rodriguez JD; Brown KD
Otol Neurotol; 2021 Jul; 42(6):906-911. PubMed ID: 33577243
[TBL] [Abstract][Full Text] [Related]
18. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Associated CD163
Guo F; Feng YC; Zhao G; Zhang R; Cheng ZZ; Kong WN; Wu HL; Xu B; Lv X; Ma XM
Cancer Manag Res; 2020; 12():5831-5843. PubMed ID: 32765086
[TBL] [Abstract][Full Text] [Related]
20. Natural History of Growing Sporadic Vestibular Schwannomas: An Argument for Continued Observation Despite Documented Growth in Select Cases.
Marinelli JP; Lees KA; Lohse CM; Driscoll CLW; Neff BA; Link MJ; Van Gompel JJ; Carlson ML
Otol Neurotol; 2020 Oct; 41(9):e1149-e1153. PubMed ID: 32925859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
